Advertisement

French national consensus clinical guidelines for the management of ulcerative colitis

      Abstract

      Background

      Ulcerative colitis (UC) is a chronic inflammatory bowel disease of multifactorial etiology that primarily affects the colonic mucosa. The disease progresses over time, and clinical management guidelines should reflect its dynamic nature. There is limited evidence supporting UC management in specific clinical situations, thus precluding an evidence-based approach.

      Aim

      To use a formal consensus method – the nominal group technique (NGT) – to develop a clinical practice expert opinion to outline simple algorithms and practices, optimize UC management, and assist clinicians in making treatment decisions.

      Methods

      The consensus was developed by an expert panel of 37 gastroenterologists from various professional organizations with experience in UC management using the qualitative and iterative NGT, incorporating deliberations based on the European Crohn's and Colitis Organisation recommendations, recent reviews of scientific literature, and pertinent discussion topics developed by a steering committee. Examples of clinical cases for which there are limited evidence-based data from clinical trials were used. Two working groups proposed and voted on treatment algorithms that were then discussed and voted for by the nominal group as a whole, in order to reach a consensus.

      Results

      A clinical practice guideline covering management of the following clinical situations was developed: (i) moderate and severe UC; (ii) acute severe UC; (iii) pouchitis; (iv) refractory proctitis, in the form of treatment algorithms.

      Conclusions

      Given the limited available evidence-based data, a formal consensus methodology was used to develop simple treatment guidelines for UC management in different clinical situations that is now accessible via an online application.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chouraki V.
        • Savoye G.
        • Dauchet L.
        • et al.
        The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988–2007).
        Alimentary Pharmacology & Therapeutics. 2011; 33: 1133-1142
        • Gunesh S.
        • Thomas G.A.
        • Williams G.T.
        • et al.
        The incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996–2005.
        Alimentary Pharmacology & Therapeutics. 2008; 27: 211-219
        • Edouard A.
        • Paillaud M.
        • Merle S.
        • et al.
        Incidence of inflammatory bowel disease in the French West Indies (1997–1999).
        Gastroenterologie Clinique et Biologique. 2005; 29: 779-783
        • Molinie F.
        • Gower-Rousseau C.
        • Yzet T.
        • et al.
        Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988–1999).
        Gut. 2004; 53: 843-848
        • Molodecky N.A.
        • Soon I.S.
        • Rabi D.M.
        • et al.
        Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.
        Gastroenterology. 2012; 142 (quiz e30): 46-54.e42
        • Ghosh S.
        • Mitchell R.
        Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey.
        Journal of Crohn's & Colitis. 2007; 1: 10-20
        • Danese S.
        • Fiocchi C.
        Ulcerative colitis.
        New England Journal of Medicine. 2011; 365: 1713-1725
        • Adams S.M.
        • Bornemann P.H.
        Ulcerative colitis.
        American Family Physician. 2013; 87: 699-705
        • Cosnes J.
        • Gower-Rousseau C.
        • Seksik P.
        • et al.
        Epidemiology and natural history of inflammatory bowel diseases.
        Gastroenterology. 2011; 140: 1785-1794
        • Ordas I.
        • Eckmann L.
        • Talamini M.
        • et al.
        Ulcerative colitis.
        Lancet (London, England). 2012; 380: 1606-1619
        • Travis S.P.
        • Stange E.F.
        • Lemann M.
        • et al.
        European evidence-based consensus on the management of ulcerative colitis: current management.
        Journal of Crohn's & Colitis. 2008; 2: 24-62
        • Mowat C.
        • Cole A.
        • Windsor A.
        • et al.
        Guidelines for the management of inflammatory bowel disease in adults.
        Gut. 2011; 60: 571-607
        • Kornbluth A.
        • Sachar D.B.
        Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.
        American Journal of Gastroenterology. 2010; 105 (quiz 524): 501-523
        • Dignass A.
        • Lindsay J.O.
        • Sturm A.
        • et al.
        Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 2: Current management.
        Journal of Crohn's & Colitis. 2012; 6: 991-1030
        • Dignass A.
        • Eliakim R.
        • Magro F.
        • et al.
        Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 1: Definitions and diagnosis.
        Journal of Crohn's & Colitis. 2012; 6: 965-990
        • Bianchi Porro G.
        • Cassinotti A.
        • Ferrara E.
        • et al.
        Review article: the management of steroid dependency in ulcerative colitis.
        Alimentary Pharmacology & Therapeutics. 2007; 26: 779-794
        • Shen B.
        • Lashner B.A.
        Diagnosis and treatment of pouchitis.
        Gastroenterology & Hepatology. 2008; 4: 355-361
        • Gallagher M.
        • Hares T.
        • Spencer J.
        • et al.
        The nominal group technique: a research tool for general practice?.
        Family Practice. 1993; 10: 76-81
        • Haute Autorité de Santé (HAS)
        Guide méthodologique. Élaboration de recommandations de bonne pratique. Méthode Recommandations par consensus formalisé.
        2010 December
        • Vitale M.G.
        • Riedel M.D.
        • Glotzbecker M.P.
        • et al.
        Building consensus: development of a Best Practice Guideline (BPG) for surgical site infection (SSI) prevention in high-risk pediatric spine surgery.
        Journal of Pediatric Orthopedics. 2013; 33: 471-478
        • ter Haar N.M.
        • Oswald M.
        • Jeyaratnam J.
        • et al.
        Recommendations for the management of autoinflammatory diseases.
        Annals of the Rheumatic Diseases. 2015; 74: 1636-1644
        • Murphy M.K.
        • Black N.A.
        • Lamping D.L.
        • et al.
        Consensus development methods, and their use in clinical guideline development.
        Health Technology Assessment. 1998; 2 (1–88): i-iv
        • D’Haens G.
        • Sandborn W.J.
        • Feagan B.G.
        • et al.
        A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
        Gastroenterology. 2007; 132: 763-786
        • Schroeder K.W.
        • Tremaine W.J.
        • Ilstrup D.M.
        Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.
        New England Journal of Medicine. 1987; 317: 1625-1629